Pierluigi Antonelli

Pierluigi Antonelli

Corporate Officer/Principal bij FRESENIUS SE & CO. KGAA
Health Technology
Health Services
Consumer Services

Profiel

Pierluigi Antonelli is currently Chief Executive Officer-Fresenius Kabi at Fresenius SE & Co. KGaA since 2023.
He is also Chairman & President, Chief Executive Officer at Fresenius Kabi AG and Chief Executive Officer at Fresenius Kabi, with both roles ongoing.
Former roles include Chief Executive Officer at Angelini Pharma Italia.
Aziende Chimiche Riunite Angelini Franc and Angelini Pharma,.
Inc. He was Chief Executive Officer at Angelini Pharma SpA from 2019 to 2023.
Other former positions include European Vice President & Managing Director-Italy at Bristol-Myers Squibb GmbH & Co. KGaA, Head-Europe Novartis Oncology at Sandoz Deutschland GmbH from 2015 to 2019, Engagement Manager at Mckinsey & Co., Inc. (Munich) from 1994 to 1998, and Senior Vice President-Italy at Merck & Co. Education includes an MBA from Northwestern University in 1994 and an undergraduate degree from The LUISS University of Rome in 1989.

Actieve functies van Pierluigi Antonelli

BedrijvenFunctieBegin
FRESENIUS SE & CO. KGAA Corporate Officer/Principal 01-03-2023
Algemeen Directeur -
Algemeen Directeur -

Eerdere bekende functies van Pierluigi Antonelli

BedrijvenFunctieEinde
Algemeen Directeur 06-02-2023
Corporate Officer/Principal 01-01-2019
Mckinsey & Co., Inc. (Munich)
Corporate Officer/Principal 01-01-1998
Corporate Officer/Principal -
Corporate Officer/Principal -
Ervaring van Pierluigi Antonelli in detail bekijken

Opleiding van Pierluigi Antonelli

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

78

Eerstegraads connecties

12

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit12

Health Services

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Services

Finance

Health Technology

Mckinsey & Co., Inc. (Munich)

Retail Trade

Finance

Health Technology

  1. Beurs
  2. Insiders
  3. Pierluigi Antonelli